the aid library

LIST OPTIONS

Filter

907

Emergency Use Designation of COVID-19 candidate vaccines: Ethical considerations for current and future COVID-19 placebo-controlled vaccine trials and trial unblinding

World Health Organization WHO (2020) C_WHO

The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This... more

Download (82)

View PDF (131)

Recommentation for an emergency use listing of COVID-19 mRNA Vaccine (NUCLEOSIDE MODIFIED) submitted by Pfizer Europe MA EEIG

World Health Organization WHO (2020) C_WHO

Download (137)

View PDF (168)

Framework for Supply Chain Management for Public Health Emergency Preparedness and Response

African Union; Africa CDC Centres for Disease Control and Prevention (2021) CC

1 February 2021

Download (119)

View PDF (161)

Report of Access to COVID-19 Tools Accelerator Facilitation Council Working Group on Diagnostics and Therapeutics

World Health Organization WHO (2022) C_WHO

This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k... more

Download (125)

View PDF (160)

Building Resilient Health Systems to Advance toward Universal Health in the Americas: Lessons from COVID-19

Pan American Health Organization (PAHO) (2023) C_WHO

This brochure presents a summary of the situation of health systems and services in the Americas as they progress toward the achievement of universal access to health and universal health coverage (universal health). The information provided presents an overview of the situation before the COVID-19 ... more

Target product profiles for animal plasma-derived antivenoms: antivenoms for treatment of snakebite envenoming in sub-Saharan Africa

World Health Organisation (WHO) (2023) C_WHO

This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document: Broad spectrum Pan-African polyvalent antivenoms: products ... more

Download (1851)

View PDF (836)

National Policy on Prevention and Containment of Antimicrobial Resistance

Ministry of Health, Kenya (2017) C1

Download (140)

View PDF (187)

Republic of Kenya: National Policy on Prevention and Containment of Antimicrobial Resistance

Government of Kenya (2017) C2

Antimicrobial resistance (AMR) is a global threat that requires urgent collaborative action within and among countries. AMR makes standard treatments ineffective and facilitates the spread of antimicrobial resistant infections rendering communities vulnerable. The Ministry of Health (MOH) and Minist... more

WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update
recommended

Dennis Falzon, Elizabeth Harausz, Ernesto Jaramillo et al. World Health Organization (WHO) (2016) C_WHO

Download (806)

View PDF (1731)

Community Case Management of Malaria in Urban Settings

Mary Amuyunzu-Nyamongo WHO, TDR (2011)

A feasibility study in five African sites

Guideline on the Use of Devices for Adult Male Circumcision for HIV Prevention

Julia Samuelson, Rachel Baggaley, Gottfried Hirnschall et al World Health Organization (2013) C_WHO

Male circumcision reduces a man’s risk of heterosexual acquisition of HIV by about 60%. This guideline provides an evidence-based recommendation on the use of adult male circumcision devices for HIV prevention in public health programmes in high HIV prevalence, resource-limited settings. It also p... more